Citation Impact
Citing Papers
Human Papillomavirus 16 E7 Oncoprotein Attenuates DNA Damage Checkpoint Control by Increasing the Proteolytic Turnover of Claspin
2009
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
2010 StandoutScience
Molecular Analysis of Commensal Host-Microbial Relationships in the Intestine
2001 StandoutScience
Requirement of bic/microRNA-155 for Normal Immune Function
2007 StandoutScience
Human Papillomavirus E7 Oncoprotein Overrides the Tumor Suppressor Activity of p21Cip1 in Cervical Carcinogenesis
2009
Human Papillomaviruses and the Interferon Response
2009
An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice
2009
The DNA-damage response in human biology and disease
2009 StandoutNature
Prevention of cervical cancer through papillomavirus vaccination
2004
Immunology of the human papilloma virus in relation to cancer
1994
Essential role of mouse telomerase in highly proliferative organs
1998 StandoutNatureNobel
Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen
2001
Vaccination against papillomavirus in cattle
1997
Activated Protein Kinase C Directly Phosphorylates the CD34 Antigen in Acute Lymphoblastic Leukemia Cells
1992
Massively parallel manipulation of single cells and microparticles using optical images
2005 StandoutNature
Preventive and therapeutic vaccines for human papillomavirus-associated cervical cancers
2000
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
2000 Standout
DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells
2010
Human papillomavirus oncoproteins: pathways to transformation
2010 Standout
Evaluation of HBs, HBc, and frCP Virus-Like Particles for Expression of Human Papillomavirus 16 E7 Oncoprotein Epitopes
2002
A hantavirus nucleocapsid protein segment exposed on hepatitis B virus core particles is highly immunogenic in mice when applied without adjuvants or in the presence of pre-existing anti-core antibodies
2005
Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7-derived peptide.
1997
Chimeric virus-like particles for the delivery of an inserted conserved influenza A-specific CTL epitope
2008
Regulation of the Cdk inhibitor p27 and its deregulation in cancer
2000
Expression of myeloid differentiation antigens in acute nonlymphocytic leukemia: Increased concentration of CD33 antigen predicts poor outcome—A report from the childrens cancer study group
1992
Differential Analysis of Human Leukocytes by Dielectrophoretic Field-Flow-Fractionation
2000
Intranasal immunization with synthetic peptides corresponding to the E6 and E7 oncoproteins of human papillomavirus type 16 induces systemic and mucosal cellular immune responses and tumor protection
2007
Basic mechanisms of high‐risk human papillomavirus‐induced carcinogenesis: Roles of E6 and E7 proteins
2007
Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes
1999 StandoutNobel
WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12
2004
Virus-like particles from rabbit hemorrhagic disease virus can induce an anti-tumor response
2008
Centrosome overduplication, chromosomal instability, and human papillomavirus oncoproteins
2009
Viruses in human cancers
1999 StandoutNobel
Transient expression of HPV16 E7 peptide (aa 44–60) and HPV16 L2 peptide (aa 108–120) on chimeric potyvirus-like particles using Potato virus X-based vector
2007
Virus-like particles in vaccine development
2010
IgA production without μ or δ chain expression in developing B cells
2001
Chimeric Virus-like Particles of the Human Papillomavirus Type 16 (HPV 16) as a Prophylactic and Therapeutic Vaccine
1999
The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2
1997
Tolerance and Autoimmunity
2001
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
Recombinant canine parvovirus-like particles express foreign epitopes in silkworm pupae
2011
Inverse correlation of cellular immune responses specific to synthetic peptides from the E6 and E7 oncoproteins of HPV-16 with recurrence of cervical intraepithelial neoplasia in a cross-sectional study
2005
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Cellular immunodeficiency enhances the progression of human papillomavirus‐associated cervical lesions
1994
Oncogenic activities of human papillomaviruses
2009
Virus-like particles as HIV-1 vaccines
2004
Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein
1997
Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue
2000 StandoutNobel
Generation of a tumor vaccine candidate based on conjugation of a MUC1 peptide to polyionic papillomavirus virus-like particles
2010
The human papillomavirus E7 oncoprotein
2008
Viruses in human cancers
1999 StandoutNobel
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
HIV-Gag VLPs presenting trimeric HIV-1 gp140 spikes constitutively expressed in stable double transfected insect cell line
2011
Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia
1997
Towards vaccines against human papillomavirus type-16 genital infections
1993
CD34 immunoexpression in stromal tumours of the gastrointestinal tract and in mesenteric fibromatoses
1994
Prophylactic and therapeutic vaccination against a mucosal papillomavirus
1993
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
1993
Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells
2001
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
In situ class switching and differentiation to IgA-producing cells in the gut lamina propria
2001 StandoutNatureNobel
Studies on vaccination against papillomaviruses: Prophylactic and therapeutic vaccination with recombinant structural proteins
1991
Tolerogenic dendritic cells generated by RelB silencing using shRNA prevent acute rejection
2012
Vaccination with human papillomavirus type 16-derived peptides using a tattoo device
2009
Human Interleukin 3: Effects on Normal and Leukemic Cells
1989
Anti-sense phosphorothioate oligonucleotides have both specific and non-specific effects on cells containing human papillomavirus type 16
1991
The role of human papillomavirus oncoproteins E6 and E7 in apoptosis
2002
Antigen CD34+ marrow cells engraft lethally irradiated baboons.
1988
Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity
2000
Direct association of the HPV16 E7 oncoprotein with cyclin A/CDK2 and cyclin E/CDK2 complexes
2008
Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein
2009
Therapeutic Vaccination for HPV Induced Cervical Cancers
2007
A genetically humanized mouse model for hepatitis C virus infection
2011 StandoutNatureNobel
Salmonella: Immune Responses and Vaccines
2001
A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer
1996
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
2013 StandoutNature
Mechanisms of genomic instability in human cancer: Insights from studies with human papillomavirus oncoproteins
2003
Recent advances in the growth and isolation of primitive human haemopoietic progenitor cells
1992
Delivery of a foreign epitope by sharing amino acid residues with the carrier matrix
2009
E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain
2006
A Novel Human DnaJ Protein, hTid-1, a Homolog of the Drosophila Tumor Suppressor Protein Tid56, Can Interact with the Human Papillomavirus Type 16 E7 Oncoprotein
1998
Multiple Functions of Jab1 Are Required for Early Embryonic Development and Growth Potential in Mice
2004 StandoutNobel
In-cell PCR from mRNA: amplifying and linking the rearranged immunoglobulin heavy and light chain V-genes within single cells
1992 StandoutNobel
Angiogenesis as a therapeutic target
2005 StandoutNature
Expression of CD34 in endothelial cells, hematopoietic progenitors and nervous cells in fetal and adult mouse tissues
1995
Expression of Human papillomavirus 16 E7ggg oncoprotein on N- and C-terminus of Potato virus X coat protein in bacterial and plant cells
2011
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Enhancement of Sindbis Virus Self-Replicating RNA Vaccine Potency by Targeting Antigen to Endosomal/Lysosomal Compartments
2001
Papillomavirus Prophylactic Vaccines: Established Successes, New Approaches
2009
Chimeric Human Papillomavirus Type 16 (HPV-16) L1 Particles Presenting the Common Neutralizing Epitope for the L2 Minor Capsid Protein of HPV-6 and HPV-16
2003
Isolation of Putative Progenitor Endothelial Cells for Angiogenesis
1997 StandoutScience
Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses
2000
Multilineage Potential of Adult Human Mesenchymal Stem Cells
1999 StandoutScience
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma
1991
Two types of murine CD34 mRNA generated by alternative splicing
1992
Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells
2001 StandoutNobel
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
Human Papillomavirus Type 16 E7 Oncoprotein Associates with the Centrosomal Component γ-Tubulin
2007
Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer
2007
New Approaches to Immunotherapy for HPV Associated Cancers
2011
Disruption of the G 1 /S Transition in Human Papillomavirus Type 16 E7-Expressing Human Cells Is Associated with Altered Regulation of Cyclin E
1998
Evidence for engraftment of donor-type multipotent CD34+ cells in a patient with selective T-lymphocyte reconstitution after bone marrow transplantation for B-SCID
1994
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.
1996 Standout
Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair
1994 Standout
Established Human Papillomavirus Type 16-Expressing Tumors Are Effectively Eradicated Following Vaccination with Long Peptides
2002
Rbx1, a Component of the VHL Tumor Suppressor Complex and SCF Ubiquitin Ligase
1999 StandoutScienceNobel
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Interactions Between the Microbiota and the Immune System
2012 StandoutScience
The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability.
2002
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
1996 StandoutScience
Enhancement of Sindbis Virus Self-Replicating RNA Vaccine Potency by Linkage ofMycobacterium tuberculosisHeat Shock Protein 70 Gene to an Antigen Gene
2001 StandoutNobel
Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model
1998
Commensal Host-Bacterial Relationships in the Gut
2001 StandoutScience
Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene.
2000
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Two distinctive pathways for recruitment of naïve and primed IgM+B cells to the gut lamina propria
2005 StandoutNobel
Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut
2004 StandoutNobel
Human Papillomavirus Type 16 E7 Oncoprotein Can Induce Abnormal Centrosome Duplication through a Mechanism Independent of Inactivation of Retinoblastoma Protein Family Members
2003
Modulation of type M 2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein
1999
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
1998 StandoutScience
A Primitive T Cell-Independent Mechanism of Intestinal Mucosal IgA Responses to Commensal Bacteria
2000 Science
A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens
1998
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
Cross-presentation of tumor antigens by bone marrow–derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression
2001
The von Hippel–Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal
1998
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Does the Immune System See Tumors as Foreign or Self?
2003
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors
1986
T-Independent Immune Response: New Aspects of B Cell Biology
2000 StandoutScienceNobel
Immunizations with Chimeric Hepatitis B Virus-Like Particles to Induce Potential Anti-Hepatitis C Virus Neutralizing Antibodies
2007
Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells
1995
Papillomavirus E6 and E7 proteins and their cellular targets
2007
High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma
2006
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
1997 StandoutScience
Deterministic hydrodynamics: Taking blood apart
2006
Expression of the CD34 gene in vascular endothelial cells
1990
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia
2009 StandoutNobel
Activated protein kinase C directly phosphorylates the CD34 antigen on hematopoietic cells.
1990
Human Papillomavirus Type 16 E7 Oncoprotein Associates with E2F6
2008
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
2002 StandoutNobel
Immunological Response to Parenteral Vaccination with Recombinant Hepatitis B Virus Surface Antigen Virus-Like Particles Expressing Helicobacter pylori KatA Epitopes in a Murine H. pylori Challenge Model
2011
Direct Activation of Cyclin-Dependent Kinase 2 by Human Papillomavirus E7
2003
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers
2000
Enhancement of Sindbis Virus Self-Replicating RNA Vaccine Potency by Linkage of Herpes Simplex Virus Type 1 VP22 Protein to Antigen
2001
CD34-deficient mice have reduced eosinophil accumulation after allergen exposure and show a novel crossreactive 90-kD protein
1996 StandoutNobel
Evidence for Protection against Chronic Hepatitis C Virus Infection in Chimpanzees by Immunization with Replicating Recombinant Vaccinia Virus
2008
Works of Robert W. Tindle being referenced
Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen
1996
Immune evasion in human papillomavirus-associated cervical cancer
2002
Recombinant Kunjin virus replicon vaccines induce protective T-cell immunity against human papillomavirus 16 E7-expressing tumour
2004
Identification of B epitopes in human papillomavirus type 16 E7 open reading frame protein
1990
Differences in the effectiveness of delivery of B- and CTL-epitopes incorporated into the Hepatitis B core antigen (HBcAg) c/e1-region
1999
Expression of human papillomavirus type 16 E7 protein by recombinant baculovirus and use for the detection of E7 antibodies in sera from cervical carcinoma patients
1993
Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific
1994
Immunology of Anogenital Human Papillomavirus (HPV) Infection
1990
Chimeric Hepatitis B Core Antigen Particles Containing B- and Th-Epitopes of Human Papillomavirus Type 16 E7 Protein Induce Specific Antibody and T-Helper Responses in Immunised Mice
1994
A polytope DNA vaccine elicits multiple effector and memory CTL responses and protects against human papillomavirus 16 E7-expressing tumour
2004
Potential strategies utilised by papillomavirus to evade host immunity
1999
Human papillomavirus (HPV) type 18 E7 protein is a short-lived steroid-inducible phosphoprotein in HPV-transformed cell lines
1994
Human papillomarivus vaccines for cervical cancer
1996
Presentation of the HPV16E7 Protein by Skin Grafts Is Insufficient to Allow Graft Rejection in an E7-Primed Animal
1997
Immune Response to Human Papillomaviruses and the Prospects for Human Papillomavirus-Specific Immunisation
1994
Peptide polymerisation facilitates incorporation into ISCOMs and increases antigen-specific IgG2a production
1995
Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine
2003
Isolation and characterization of human hematopoietic progenitor cells: an effective method for positive selection of CD34+ cells.
1992
Provision of 4-1BB Ligand Enhances Effector and Memory CTL Responses Generated by Immunization with Dendritic Cells Expressing a Human Tumor-Associated Antigen
2003
Hepatitis B Surface Antigen Vector Delivers Protective Cytotoxic T-Lymphocyte Responses to Disease-Relevant Foreign Epitopes
2006
Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein.
1996
A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes.
1991
Peripheral tolerance to human papillomavirus E7 oncoprotein occurs by cross-tolerization, is largely Th-2-independent, and is broken by dendritic cell immunization.
2000
Expression of HPCA‐1 and HLA‐DR antigens on growth factor‐ and stroma‐dependent colony forming cells
1987
Paucity of functional CTL epitopes in the E7 oncoprotein of cervical cancer associated human papillomavirus type 16
2003
Th2-Type CD4+ Cells Neither Enhance nor Suppress Antitumor CTL Activity in a Mouse Tumor Model
1998
Cell mediated immunity to papillomaviruses
1999
A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow
1985
A vaccine conjugate of ‘ISCAR’ immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants
1995
Antigenicity and Immunogenicity of Novel Chimeric Hepatitis B Surface Antigen Particles with Exposed Hepatitis C Virus Epitopes
2001
Identification of a membrane glycoprotein associated with haemopoietic progenitor cells
1985